DUBLIN–(BUSINESS WIRE)–The “Syringe Pumps Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering. The Syringe Pumps Market has DUBLIN–(BUSINESS WIRE)–The “Syringe Pumps Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering. The Syringe Pumps Market has

Trends Shaping the $6.29 Billion Syringe Pumps Market, 2025-2032: Adoption of Smart Infusion Pump Platforms Drives Growth – ResearchAndMarkets.com

2025/12/17 02:49
5 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

DUBLIN–(BUSINESS WIRE)–The “Syringe Pumps Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering.

The Syringe Pumps Market has shown impressive growth, expanding from USD 4.39 billion in 2024 to USD 4.58 billion in 2025, with projections indicating a growth trajectory leading to USD 6.29 billion by 2032. Driven by the need for precision in infusion therapy, the adoption of innovative syringe pump technologies is elevating patient safety and operational efficiency across healthcare settings. Increased demand for precision dosing, fueled by advancements in pump design and sensor integration, is transforming care delivery in critical care and ambulatory environments.

Technological Advancements and Market Expansion

Healthcare providers are increasingly adopting precision infusion devices to enhance treatment outcomes. Syringe pumps are now vital in delivering controlled medication doses, such as analgesics, antibiotics, and hormonal therapies. As the healthcare landscape shifts towards minimally invasive procedures and personalized medicine, there is a growing need for accurate flow control mechanisms. This trend is further supported by the expansion of home healthcare services and the rise of telemedicine, allowing patients to manage complex therapies remotely.

Digital Transformation and IoT Integration

Digital transformation has significantly reshaped the syringe pump industry over the past decade, with connected platforms and cloud-based solutions enabling remote monitoring and device management. Integration with hospital information systems allows clinicians to efficiently track infusion parameters and intervene when necessary. The rise of the Internet of Medical Things (IoMT) has promoted real-time telemetry, empowering healthcare teams with advanced analytics to optimize therapy regimens. Devices equipped with smart sensors are becoming essential components of autonomous drug delivery systems.

Key Takeaways from This Report

  • Syringe pumps are crucial in advancing precision infusion therapy and enhancing patient safety.
  • Technological advancements, such as IoT integration, are instrumental in driving innovation and improving clinical outcomes.
  • The response to tariff adjustments involves strategic sourcing and inventory management to maintain cost efficiency.
  • Localized production and strategic alliances in high-growth markets are key to capturing emerging opportunities.

Key Attributes

Report Attribute Details
No. of Pages 197
Forecast Period 2025-2032
Estimated Market Value (USD) in 2025 $4.58 Billion
Forecasted Market Value (USD) by 2032 $6.29 Billion
Compound Annual Growth Rate 4.6%
Regions Covered Global

Key Topics Covered

1. Preface

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Integration of IoT connectivity enabling remote monitoring and predictive maintenance for syringe pumps

5.2. Adoption of smart infusion pump platforms with built-in drug libraries and dose error reduction software

5.3. Development of battery-operated compact wearable syringe pumps for ambulatory and home infusion therapies

5.4. Utilization of AI-driven flow rate optimization algorithms to minimize overinfusion and underinfusion risks

5.5. Emergence of multi-channel syringe pump systems supporting simultaneous infusion of multiple therapies

5.6. Focus on antimicrobial and biocompatible materials to reduce infection risks in long-term infusion devices

5.7. Implementation of cybersecurity frameworks protecting networked syringe pumps from unauthorized access

5.8. Regulatory push towards interoperability standards for seamless integration with electronic health records

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Syringe Pumps Market, by Product Type

8.1. Infusion

8.2. Withdrawal

9. Syringe Pumps Market, by Material Type

9.1. Glass

9.2. Plastic

9.3. Stainless

10. Syringe Pumps Market, by Mode Of Operation

10.1. Electronic

10.2. Manual

11. Syringe Pumps Market, by End User

11.1. Ambulatory Surgical Centers

11.2. Food & Beverage

11.3. Home Healthcare

11.4. Hospitals & Clinics

11.5. Pharmaceutical

11.6. Research Institutes

12. Syringe Pumps Market, by Region

12.1. Americas

12.1.1. North America

12.1.2. Latin America

12.2. Europe, Middle East & Africa

12.2.1. Europe

12.2.2. Middle East

12.2.3. Africa

12.3. Asia-Pacific

13. Syringe Pumps Market, by Group

13.1. ASEAN

13.2. GCC

13.3. European Union

13.4. BRICS

13.5. G7

13.6. NATO

14. Syringe Pumps Market, by Country

14.1. United States

14.2. Canada

14.3. Mexico

14.4. Brazil

14.5. United Kingdom

14.6. Germany

14.7. France

14.8. Russia

14.9. Italy

14.10. Spain

14.11. China

14.12. India

14.13. Japan

14.14. Australia

14.15. South Korea

15. Competitive Landscape

15.1. Market Share Analysis

15.2. FPNV Positioning Matrix

15.3. Competitive Analysis

The companies profiled in this Syringe Pumps market report include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cavro Scientific Instruments by Tecan Group Ltd.
  • Cetoni GmbH
  • Chemyx, Inc.
  • Cole-Parmer Instrument Company LLC
  • Danaher Corporation
  • Fresenius Kabi AG
  • GE HealthCare Technologies, Inc.
  • Hamilton & Company Limited.
  • Harvard Apparatus Regenerative Technology, Inc.
  • ICU Medical, Inc.
  • IMI plc
  • Isco by Teledyne Technologies, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Nihon Kohden Corporation
  • Siemens Healthineers AG
  • Terumo Corporation
  • The New Era Pump Systems, Inc.
  • World Precision Instruments GmbH

For more information about this report visit https://www.researchandmarkets.com/r/23g0hd

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Market Opportunity
Smart Blockchain Logo
Smart Blockchain Price(SMART)
$0.005181
$0.005181$0.005181
-0.51%
USD
Smart Blockchain (SMART) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Warning: npm core package axios version 1.14.1 is under active supply chain attacks.

Warning: npm core package axios version 1.14.1 is under active supply chain attacks.

PANews reported on March 31 that, according to Cointelegraph, Socket detected an active supply chain attack on version 1.14.1 of the npm core package axios. Attackers
Share
PANews2026/03/31 13:03
Won-pegged stablecoin KRW1 launches in South Korea on Avalanche

Won-pegged stablecoin KRW1 launches in South Korea on Avalanche

Stablecoin development in South Korea has advanced with the launch of KRW1, a won-pegged token issued on the Avalanche blockchain. Seoul-based digital asset firm BDACS announced the launch of KRW1 on September 17, a stablecoin fully backed by South Korean…
Share
Crypto.news2025/09/18 15:48
First Multi-Asset Crypto ETP Opens Door to Institutional Adoption

First Multi-Asset Crypto ETP Opens Door to Institutional Adoption

The post First Multi-Asset Crypto ETP Opens Door to Institutional Adoption appeared on BitcoinEthereumNews.com. The US Securities and Exchange Commission (SEC) has officially approved the Grayscale Digital Large Cap Fund (GDLC) for trading on the stock exchange. The decision comes as the SEC also relaxes ETF listing standards. This approval provides easier access for traditional investors and signals a major regulatory shift, paving the way for institutional capital to flow into the crypto market. Grayscale Races to Launch the First Multi-Asset Crypto ETP According to Grayscale CEO Peter Mintzberg, the Grayscale Digital Large Cap Fund ($GDLC) and the Generic Listing Standards have just been approved for trading. Sponsored Sponsored Grayscale Digital Large Cap Fund $GDLC was just approved for trading along with the Generic Listing Standards. The Grayscale team is working expeditiously to bring the FIRST multi #crypto asset ETP to market with Bitcoin, Ethereum, XRP, Solana, and Cardano#BTC #ETH $XRP $SOL… — Peter Mintzberg (@PeterMintzberg) September 17, 2025 The Grayscale Digital Large Cap Fund (GDLC) is the first multi-asset crypto Exchange-Traded Product (ETP). It includes Bitcoin (BTC), Ethereum (ETH), XRP, Solana (SOL), and Cardano (ADA). As of September, the portfolio allocation was 72.23%, 12.17%, 5.62%, 4.03%, and 1% respectively. Grayscale Digital Large Cap Fund (GDLC) Portfolio Allocation. Source: Grayscale Grayscale Investments launched GDLC in 2018. The fund’s primary goal is to expose investors to the most significant digital assets in the market without requiring them to buy, store, or secure the coins directly. In July, the SEC delayed its decision to convert GDLC from an OTC fund into an exchange-listed ETP on NYSE Arca, citing further review. However, the latest developments raise investors’ hopes that a multi-asset crypto ETP from Grayscale will soon become a reality. Approval under the Generic Listing Standards will help “streamline the process,” opening the door for more crypto ETPs. Ethereum, Solana, XRP, and ADA investors are the most…
Share
BitcoinEthereumNews2025/09/18 13:31